Search - tctmd.com

Displaying 961 - 980 of 1426

Sort: Relevancy | Date

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Adjunctive Cilostazol Improves Ischemic Outcomes in Carotid Artery Stenting Patients

January 01, 2014

News Daily News

Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA

Yael L. Maxwell

January 01, 2014

News Daily News

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

January 01, 2014

News Daily News

Cilostazol Adyuvante Mejora los Resultados Isquémicos en Pacientes Implantados de Stent en la Arteria Carótida

January 01, 2014

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

L.A. McKeown

December 30, 2013

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

Meta Análisis: La PCI No añade Beneficio alguno al Tratamiento Médico en Pacientes con Isquemia Demostrada

Yael L. Maxwell

December 08, 2013

News Daily News

No Rebound Effect after Clopidogrel Cessation in Stable Patients

December 05, 2013

News Daily News

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

December 05, 2013

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Daily News

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

L.A. McKeown

November 01, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Conference News TCT 2013

Misperceptions Persist Regarding ‘Inappropriate’ PCI

October 30, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

Advertisement

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Adjunctive Cilostazol Improves Ischemic Outcomes in Carotid Artery Stenting Patients

Watchman Logra un Apoyo Importante del Panel de Asesores de la FDA

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

Cilostazol Adyuvante Mejora los Resultados Isquémicos en Pacientes Implantados de Stent en la Arteria Carótida

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Meta Análisis: La PCI No añade Beneficio alguno al Tratamiento Médico en Pacientes con Isquemia Demostrada

No Rebound Effect after Clopidogrel Cessation in Stable Patients

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

Los Hallazgos avalan una Duración de la Terapia Antiplaquetaria Doble mayor que 3 Meses en Pacientes SCA

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

OPTIMIZE: 3-Month DAPT Safe with ZES

Misperceptions Persist Regarding ‘Inappropriate’ PCI

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content